Home > Polymers, Specialty Chemicals & Advanced Materials > Glutathione Market
Global Glutathione Market size was over USD 195 million in 2020 and is estimated to grow at over 7% CAGR up to 2027 owing to wide application of glutathione in numerous industries such as pharmaceutical, cosmetic, food and nutraceuticals. Growing adoption of glutathione in chemotherapy should promote market growth in the coming timeframe.
Glutathione is an important antioxidant in the human body, which helps combat free radicals, detoxify chemicals which are naturally created by human body, and also detoxifies drugs and pollutants present in the environment. Moreover, glutathione provides protection against the harmful effects of radiation and chemotherapy for cancer along with treatment for weakened immune systems or infertility. These benefits of the product should fuel the glutathione market share in the pharmaceutical and food industry worldwide.
To get more details on this report: Request Free Sample PDF
The outbreak of the COVID-19 pandemic and lockdown imposed by governments to prevent the spread of COVID-19 has resulted in disrupted supply chains. Also, the spread of COVID-19 has disrupted worker productivity and has led to shortages of production in different industrial sectors. In addition, the consciousness among the consumers towards health, cleanliness and healthy habits are on rise.
Report Coverage | Details |
---|---|
Base Year: | 2020 |
Market Size in 2020: | USD 316.56 Million |
Forecast Period: | 2021 to 2027 |
Forecast Period 2021 to 2027 CAGR: | 7.1% |
2027 Value Projection: | USD 197.13 Million |
Historical Data for: | 2016 to 2020 |
No. of Pages: | 180 |
Tables, Charts & Figures: | 272 |
Segments covered: | Product |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
To get more details on this report: Request Free Sample PDF
Glutathione plays an important role in the boosting immune system and aids to fight against various pollutants present in the environment. This property supports the glutathione market demand in the COVID-19 pandemic as well and anticipated to grow over the coming years too.
The stringent regulations laid down by governing bodies of different regions on the manufacturing, labeling and product consumption are likely to restrain the glutathione market growth of to some extent during the forecast period. For instance, FDA communicated with the manufacturers of L-glutathione, to confirm that the ingredient is not proposed for use in sterile drugs, where the L-glutathione is only promoted in the U.S. for use in dietary supplements. However, manufacturer also advise their U.S. customers about the application of L-glutathione in sterile drugs, to sustain in the market.
To get more details on this report: Request Free Sample PDF
Reduced glutathione market size should surpass USD 200 million by 2027 and is anticipated to show growth over 7.0% CAGR up to 2027. There is a continuous rise in the cancer cases around the globe, which is the second leading cause of death globally. According to World Health Organization, in 2020 cancer was responsible for 9.6 million deaths. There are several factors responsible for rising cancer prevalence such as population growth, change in lifestyle, increasing number of smokers, and tobacco use. Therefore, rising cancer burden around the globe should propel the growth for reduced glutathione, owing to its suitability to prevent harmful side effects of chemotherapy to cancer patients.
To get more details on this report: Request Free Sample PDF
The demand for manufacturing drugs in the region in high, owing to the presence of several pharmaceutical manufacturers including Johnson and Pfizer & Johnson. Hence, wide presence of pharmaceutical manufacturers in the region generates huge opportunity for glutathione market as the product is highly utilized in the manufacture of many pharmaceutical products. North America led by U.S. is predicted register over 7% gains at the end of 2027. The growth is attributed to several benefits associated with the product such as tissue repairing & building and immune system boosting. The product is also utilized for treating numerous diseases which include asthma, cataract, and anemia.
Global glutathione industry consists of various major players including Kyowa Hakko Bio Co., Ltd., Nissor Pharmaceuticals Ltd. Shenzhen GSH Bio-tech Co., Ltd. and KOHJIN Life Sciences Co., Ltd. Players in the market are engaged in collaboration and partnership with other operators, to expand into the untapped market. Also, companies are adopting joint ventures with the players in emerging countries, investment for new manufacturing units and research & development to gain the strong footprint and portfolio in the global market.
In 2019, Kyowa Hakko Bio Co. Ltd company has extended its global reach with a new product Setria glutathione in Indonesia. The company is committed to developing science-backed products that support wellness and treatment of diseases. The product is patented, allergen-free, and clinically studied form of glutathione, which helps to increase the antioxidants in the human body.
In 2015, KOHJIN Life Sciences company conducted study on the benefits of Glutathione for Lipid Metabolism and Sports Nutrition. The studies prove, that oral intake of GSH, resulted in a Mitochondrial DNA & AMP, and PGC-1α activated-kinase expression in skeletal muscle. Also, the study show that glutathione improves lipid metabolism and acidification in muscle during exercise.
The global glutathione market report includes in-depth coverage of the industry with estimates & forecast in terms of volume in Kilotons & revenue in USD Million from 2016 to 2027 for the following segments:
Click here to Buy Section of this Report
The above information has been provided for the following countries: